RBC Capital Reiterates Outperform on Colgate-Palmolive, Maintains $102 Price Target

Benzinga Newsdesk www.benzinga.com Negative 84.2%

Neg 84.2% Neu 0% Pos 0%

RBC Capital analyst Nik Modi reiterates Colgate-Palmolive (NYSE:CL) with a Outperform and maintains $102 price target.

Comments

No comments yet. Be the first!